Keymed Biosciences Inc.

HK$69.30As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2162Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 5Y CAGR 2.09%
Div yield —
ROE 21.49%
Biotechnology
Beta (5Y) (0.04)
PE TTM 22.12
TSR TTM 15.02%
Mkt cap HK$20.42B
ROIC (33.51%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$70
0.77%
(66.48%)
Hold 6|12|11|9|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.65
0.73
0.77
0.76
(0.82%)
6.10%
17.76%
17.09%
Revenue¥B
1.352
1.351
1.401
1.450
4.55%
1.86%
0.16%
5.45%
Peers (US$2.604B)
Cap (US$)
PE
2.865B
—
Capital
TTM
5Y
10Y
Leveragex
1.031
0.175
0.141
EBIT/Intx
1.455
0.185
0.187
Own earn%
28.42
(88.02)
(73.16)
Sh yield%
21.74
38.89
39.52
Owners
Insiders/Inst%
8.14
54.08
Short interest%
2.02
SBC / revenue%
4.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
16–25
$1 testx
0.1
Incr. ROIC%
2